The global companion animal healthcare market is expected to increase by USD 10.1 billion, at a compound annual growth rate (CAGR) of 7.3% from 2022 to 2028, according to the latest edition of the Global Companion Animal Healthcare Market Report.

The report covers market size and growth, segmentation, regional breakdowns, competitive landscape, trends and strategies for global companion animal healthcare market. It traces the market’s historic and forecast market growth. The report identifies top segments for opportunities and strategies based on market trends and leading competitors’ approaches. This study also provides an analysis of the impact of the COVID-19 crisis on the companion animal healthcare industry.

This industry report offers market estimates and forecasts of the global market, followed by a detailed analysis of the type, diagnostic, animal type, and region. The global market for companion animal healthcare can be segmented by type: therapeutics, vaccines, parasiticides, anti-infectives, medical feed additives, others. In 2021, the therapeutics segment made up the largest share of revenue generated by the companion animal healthcare market. Companion animal healthcare market is further segmented by diagnostic: immunodiagnostic tests, molecular diagnostics, diagnostic imaging, others. The immunodiagnostic tests segment was the largest contributor to the global companion animal healthcare market in 2021. Based on animal type, the companion animal healthcare market is segmented into: dogs, cats, others. The dogs segment is estimated to account for the largest share of the global companion animal healthcare market. On the basis of region, the companion animal healthcare market also can be divided into: North America, Europe, Asia-Pacific, MEA (Middle East and Africa), Latin America. North America held the largest share of the global companion animal healthcare market in 2021 and is anticipated to hold its share during the forecast period.

Market Segmentation
By type: therapeutics, vaccines, parasiticides, anti-infectives, medical feed additives, others
By diagnostic: immunodiagnostic tests, molecular diagnostics, diagnostic imaging, others
By animal type: dogs, cats, others
By region: North America, Europe, Asia-Pacific, MEA (Middle East and Africa), Latin America

The report also provides analysis of the key companies of the industry and their detailed company profiles including Boehringer Ingelheim International GmbH, Ceva Sante Animale S.A., Elanco Animal Health Incorporated, Heska Corporation, IDEXX Laboratories, Inc., Indian Immunologicals Ltd. (IIL), Merck & Co., Inc., Vetoquinol S.A., Virbac S.A., Zoetis Inc., among others.
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES

Historical & Forecast Period
This research report provides analysis for each segment from 2018 to 2028 considering 2021 to be the base year.

Scope of the Report
– To analyze and forecast the market size of the global companion animal healthcare market.
– To classify and forecast the global companion animal healthcare market based on type, diagnostic, animal type, region.
– To identify drivers and challenges for the global companion animal healthcare market.
– To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global companion animal healthcare market.
– To identify and analyze the profile of leading players operating in the global companion animal healthcare market.

Why Choose This Report
– Gain a reliable outlook of the global companion animal healthcare market forecasts from 2022 to 2028 across scenarios.
– Identify growth segments for investment.
– Stay ahead of competitors through company profiles and market data.
– The market estimate for ease of analysis across scenarios in Excel format.
– Strategy consulting and research support for three months.
– Print authentication provided for the single-user license.